Hydrogen-rich Water for Mucositis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if hydrogen-rich water can ease mouth sores caused by radiation treatment in individuals with head and neck cancer. Participants will receive either hydrogen tablets (producing hydrogen-rich water) or a placebo to compare effects. The trial seeks individuals diagnosed with head and neck cancer who are undergoing radiation therapy for more than four weeks and can eat and drink normally. As an Early Phase 1 trial, this research focuses on understanding how the treatment works in people, offering participants the opportunity to explore this potential new therapy.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that hydrogen tablets are likely to be safe for humans?
In earlier studies, tests on animals have shown that hydrogen tablets are safe. However, detailed safety information for humans remains limited. Other research suggests that hydrogen-rich water might help reduce inflammation and speed up recovery, indicating potential safety for people. This trial is in its early stages and primarily focuses on assessing safety. So far, no strong evidence of serious side effects in humans has emerged. As this is an early phase trial, researchers continue to collect safety data.12345
Why do researchers think this study treatment might be promising for mucositis?
Unlike the standard treatments for mucositis, which often involve pain management and protective barriers, hydrogen-rich water introduces a new approach by using hydrogen tablets to potentially reduce inflammation and promote healing. Researchers are excited about this treatment because hydrogen has antioxidant properties that might neutralize harmful free radicals, which are believed to contribute to tissue damage in mucositis. This innovative method could offer a gentler, more natural option for patients, potentially minimizing the side effects associated with conventional medications.
What evidence suggests that hydrogen tablets might be an effective treatment for mucositis?
This trial will compare hydrogen-rich water (HRW) with a placebo to evaluate its effectiveness in easing mucositis symptoms. Research has shown that HRW might help with mucositis, a painful swelling often caused by radiation treatment. Studies have found that HRW can protect the stomach lining in animals and boost the body's natural defenses. One study discovered that inhaling hydrogen reduced inflammation and symptoms in people with radiation-related issues. Additionally, HRW has benefited liver damage in cancer patients receiving chemotherapy. These findings suggest that HRW could effectively reduce swelling and promote healing in mucositis.12356
Who Is on the Research Team?
Kartik Mani, MD
Principal Investigator
Stony Brook University
Are You a Good Fit for This Trial?
This trial is for individuals with head and neck cancer, who are about to undergo daily radiotherapy for more than 4 weeks. Participants must be able to give consent, have a Karnofsky Performance Score of at least 70, swallow normally, and describe their pain.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Radiation
Participants undergo radiation therapy for head and neck cancer
Treatment
Participants receive hydrogen-rich water to mitigate acute mucositis during radiation therapy
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Hydrogen tablets
Find a Clinic Near You
Who Is Running the Clinical Trial?
Clare Moran
Lead Sponsor
Stony Brook University
Lead Sponsor
DrinkHRW
Collaborator